Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Netris Pharma S.A.S.

Headquarters: Lyon, France
Year Founded: 2008
Status: Private

BioCentury | Mar 12, 2025
Discovery & Translation

Science Spotlight: Killing the mesenchymal precursors that drive cancer progression

BioCentury’s roundup of translational innovations also includes blood detection of pregnancy complications, BBB-crossing antibodies, and more
BioCentury | Aug 11, 2023
Discovery & Translation

Bacteria to detect tumors; plus Netris’ mAb to block EMT in cancer and more

BioCentury’s roundup of translational innovations
BioCentury | Aug 19, 2017
Product Development

Restoring dependence

How Netris’ dependence receptor programs kill cancer stem cells missed by other drugs
BioCentury | Mar 29, 2017
Clinical News

NP137: Ph I started

BioCentury | Apr 3, 2008
Distillery Therapeutics

This Week in Therapeutics

Items per page:
1 - 6 of 6